Tag, GOP - You're IT! For the past three-plus years,

New Post Public Reply Private Reply Replies (0) Message Board
Bhawks
166
Tag, GOP - You're IT!

For the past three-plus years, you’ve had to defend your “pResident” on a daily basis.

You’ve had to come up with excuses for his inane tweets, his idiotic statements, his lies – his obvious stupidity.

You’ve had to make excuses for the big ticket issues, as well – paying hush-money to porn stars, locking kids in cages – and even bigger stuff, like giving classified information to the Russians, standing with Putin against his own country.

And then things got really sticky when you had to defend him for shaking down Ukraine in exchange for the financial aid they desperately needed – and that included having to make excuses for yourselves when you acquitted him of what amounts to treason.

Well, now it’s a whole new ballgame, isn’t it? Now you have to make excuses for your “pResident” ignoring information about Covoid-19 in order to protect his re-election campaign, and for lying about it after the fact. You have to make excuses for his incompetence in handling the pandemic, and for yourselves for enabling and supporting that incompetence.

But now you have to make excuses for people dying – people who wouldn’t have died if a competent response had been initiated at the outset, had your “pResident” and your party members not tried to convince the populace that they were safe when you knew they weren’t, had your “pResident” not decided that his poll numbers were more important than preparing the nation for what was inevitably to come.

Let me impart something most of us learned in Common Sense 101. Nothing unifies people like facing a common crisis, especially a life-or-death crisis like a pandemic. And united people tend to look for a common enemy to blame for their circumstances – especially when they realize that that enemy precipitated those circumstances, and did so to protect their political power instead of protecting them.

So guess what, Republican powers-that-be? Tag – you’re IT! You and your “pResident” are now the common enemy that allowed people’s parents, children, neighbours and friends to die. You are the reason that our first responders are risking their lives to treat the sick and the dying because they lack the protective gear and equipment to do so safely.

Your “president” is the direct cause of incalculable physical, emotional, and psychological suffering among your fellow citizens – and you are the party that is busy making excuses for him, same as always.

You know, it’s one thing to come up with bullshit PR spin to cover for dalliances with porn stars – or even inconvenient-but-damning testimony from witnesses to your “pResident’s” treason. It’s quite another thing to try to excuse-away sitting back and watching Americans sicken and die while protecting a self-serving madman who believes his re-election is more important than any one life, no less tens of thousands of lives.

So yeah, GOP – you’re IT! Now run along and spin your “pResident’s” choice to put his re-election chances above the health, safety, and financial well-being of the citizenry into being something noble. Come up with excuses as to why he withheld life-saving information from the people he swore to protect. Conjure up excuses for his self-serving lies, along with his incomparable incompetence.

And good luck trying to sell that BS in November – ‘cause I got a feeling that despite any shortages we might be facing in future, pure unadulterated bullshit ain’t gonna be flying off the shelves.


https://www.democraticunderground.com/100213300770
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Implantica's U.S. Launch Arrives With Cash Still to Burn

Updated Category News Views 0

RefluxStop has finally stepped onto American soil, and that changes the conversation around Implantica in a very real way. FDA Premarket Approval arrived on August 20, then the first U.S. procedures were completed in early November at the University of Southern California. For a small medtech outfit, clearing that regulatory gate and getting actual patients treated are...

Continue Reading
Nellie's 50% Booking Jump Reveals a Quieter Luxury

Updated Category News Views 141

Silicon Valley’s rich are apparently tired of performing wealth for strangers, and frankly, that tracks. Nellie’s 2027 forecast says its mostly tech-money clientele is moving past the old trophy case of private jets, famous resort towns, and suites priced like small houses. The prize now is privacy, a clean schedule, and somebody competent fixing the ugly little...

Continue Reading
Hyundai’s Third SUV Crown Matters Beyond the Trophy

Updated Category News Views 0

A Three-Year Streak Is Not Just Decorative Three straight SUV-brand wins can make even a cynical car watcher pause. Hyundai has been named U.S. News & World Report’s 2027 Best SUV Brand after editors assessed vehicles from 39 brands, and that is a useful bit of outside validation in a segment where nearly everybody is throwing sheet metal, screens, and marketing dollars...

Continue Reading
NextPatient’s KLAS Marks Signal Specialty Workflow Fit

Updated Category News Views 79

A 93.3 score in healthcare software deserves a second look. Not a victory lap, not a drumroll—just a serious look at whether the product is solving an annoying, expensive operational problem for specialty practices. NextPatient’s recognition in the 2026 KLAS Emerging Solutions Top 20 Report lands in that category. The company placed in the top five for improving...

Continue Reading
illumine Targets Childcare Chain Control and Risk Gaps

Updated Category News Views 131

Expansion Gets Messy Before It Gets Impressive Childcare operators do not usually stumble because they forgot how to care for children; they stumble because the back office fractures as the network grows. One center handles fees one way, another lets enrollment leads work a different funnel, and headquarters discovers too late that its reports are arguing with each other....

Continue Reading
Rehab Equipment Growth Meets a Brutal Access Gap

Updated Category News Views 151

Rehabilitation demand is piling up faster than the equipment can reach people. That is the uncomfortable fact sitting beneath Wissen Research's forecast for a global rehabilitation equipment market rising from $19.1 billion in 2026 to $25.8 billion by 2031, a 6.2% annual growth rate. It is a respectable expansion story, not some rocket-ship fairy tale. More important, it...

Continue Reading
Sinopec's Green Fuel Push Meets a Hard Reality Check

Updated Category News Views 30

A refinery giant talking about green jet fuel at a climate summit is exactly the sort of thing that makes old energy hands squint first—and then check the asset list. Sinopec did bring more than lofty language to its Nov. 16 COP31 side event in Antalya: it brought long-range energy forecasts, named fuel-production routes, hydrogen infrastructure and operating projects....

Continue Reading
Yatsen’s November 25 Report Is the Real Beauty Test

Updated Category News Views 90

Beauty shelves can hide a lot of sins, but earnings day tends to drag them into fluorescent light. Yatsen will release unaudited third-quarter 2026 financial results before the U.S. market opens on Wednesday, November 25, then management will take questions at 7:30 a.m. Eastern Time. For anyone following NYSE:YSG, this is not a results story yet. It is a calendar marker,...

Continue Reading
Dutch Solar Homes Face a 2027 Net Metering Reset Ahead

Updated Category News Views 24

A policy switch buried in a Dutch calendar is about to rearrange millions of kitchen-table energy calculations. On 1 January 2027, the Netherlands ends net metering, or salderingsregeling, and households with solar panels will no longer offset exported power against electricity bought from the grid. That is not some abstract regulatory footnote. It changes the value of...

Continue Reading
Misunderstood Brands Bets Small Cans Can Scale Growth

Updated Category News Views 190

A tiny cocktail can is a brutal little test of whether a spirits brand has legs. Misunderstood Brands is putting four 100mL offerings on the shelf just as its Wegmans distribution expands across the East Coast, and that combination matters more than another glossy flavor announcement. The company is trying to turn products people discovered in bars and restaurants into...

Continue Reading

Top 5 Most Recently Viewed Articles

DallasNews Shareholders Urged to Support Merger Deal with Hearst

Updated Category News Views 101

Overview of the DallasNews and Hearst Merger DallasNews Corporation, the parent company of The Dallas Morning News, has proposed a significant merger with Hearst, a prominent media organization. This merger offers an enticing cash value of $15.00 per share, bringing impressive benefits to shareholders. Recently, Glass Lewis, an independent proxy advisory firm, recommended...

Continue Reading
GitLab Director Karen Blasing's Recent Stock Transactions Explained

Updated Category News Views 154

Analyzing the Recent Insider Trading at GitLab GitLab Inc. (NASDAQ:GTLB) has recently drawn the attention of investors and market analysts due to stock transactions made by its director, Karen Blasing. A recent filing with the U.S. Securities and Exchange Commission revealed that Blasing sold a considerable amount of her stock holdings, totaling more than $173,000....

Continue Reading
Avenue Living's Strategic $350 Million Debenture Offering

Updated Category News Views 202

Avenue Living Announces $350 Million Senior Unsecured Debenture Offering Avenue Living (2014) LP has recently announced a significant financial move with a $350 million offering of Series B senior unsecured debentures. This opportunity is set to be priced at par and is due by September 25, 2028, indicating a long-term strategy for the company’s financing needs. Details...

Continue Reading
Fagron Reports Strong Financial Growth with Strategic Outlook

Updated Category News Views 349

Fagron's Remarkable Financial Performance Fagron, a global leader in pharmaceutical compounding, recently showcased its impressive results for the period ending December 31, 2024. The company’s financial achievements highlight significant growth across various sectors and regions in the pharmaceutical industry, reinforcing its commitment to excellence and innovation....

Continue Reading
Dizal's Sunvozertinib Receives Breakthrough Therapy Designation

Updated Category News Views 444

Dizal's Sunvozertinib Achieves Breakthrough Therapy Designation Dizal, a biopharmaceutical company dedicated to developing innovative cancer and immunological therapies, recently announced an important milestone. The Center for Drug Evaluation of China's National Medical Products Administration has granted Breakthrough Therapy Designation for sunvozertinib, aimed at...

Continue Reading